SCHEMBL18335359

SCHEMBL18335359

CCCCC/C=C\C/C=C\CCCCCCCCOC(=O)CC(CC(=O)OCCCCCCCC/C=C\C/C=C\CCCCC)NC(=O)SCCN(C)C

nearest known ligand 0.48

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.44
MGLL Q99685 1/20 0.42
CNR1 P21554 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
ALOX5 P09917 1/20 0.39
DNM1 Q05193 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18335360 1.00 FAAH (0.44) FAAHMGLLCNR1ALDH1A1MAPT
SCHEMBL20609364 0.92 FAAH (0.39) FAAHMGLLCNR1ALDH1A1MAPT
SCHEMBL18350868 0.89 MGLL (0.50) FAAHMGLLCNR1ALDH1A1MAPT
SCHEMBL18350872 0.88 FAAH (0.46) FAAHMGLLCNR1ALDH1A1MAPT
SCHEMBL18003941 0.84 FAAH (0.46) FAAHMGLLCNR1ALDH1A1MAPT
SCHEMBL18003939 0.84 FAAH (0.46) FAAHMGLLCNR1ALDH1A1MAPT
SCHEMBL18350867 0.84 DNM1 (0.44) FAAHMAPTTHRBDNM1
SCHEMBL18350953 0.83 ALDH1A1 (0.47) FAAHMGLLCNR1ALDH1A1MAPT
SCHEMBL18350847 0.82 CNR1 (0.48) MGLLCNR1ALDH1A1THRB
SCHEMBL20609402 0.82 FAAH (0.48) FAAHMGLLCNR1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250250226-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORP (JP) 2025-08-07 US disclosed
US-12319643-B2 Ionizable compounds and compositions and uses thereof NITTO DENKO CORPORATION (JP) 2025-06-03 US disclosed
US-20220242820-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2022-08-04 US disclosed
US-11384051-B2 Ionizable compounds and compositions and uses thereof NITTO DENKO CORPORATION (JP) 2022-07-12 US disclosed
US-11384051-B2 Ionizable compounds and compositions and uses thereof NITTO DENKO CORPORATION (JP) 2022-07-12 US disclosed
EP-3313449-B1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORP (JP) 2020-09-23 EP disclosed
EP-3686184-A2 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2020-07-29 EP disclosed
EP-3686184-A2 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2020-07-29 EP disclosed
US-20190127318-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2019-05-02 US disclosed
US-20190127318-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2019-05-02 US disclosed
US-10167253-B2 Ionizable compounds and compositions and uses thereof NITTO DENKO CORPORATION (JP) 2019-01-01 US disclosed
US-10167253-B2 Ionizable compounds and compositions and uses thereof NITTO DENKO CORPORATION (JP) 2019-01-01 US disclosed
EP-3313449-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF Nitto Denko Corporation (JP) 2018-05-02 EP disclosed
WO-2016210190-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2016-12-29 WO disclosed
US-20160376229-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2016-12-29 US disclosed
US-20160376229-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2016-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220242820-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NCL, RNASE1, RNMT FAAH 4419/4885MGLL 3231/4885CNR1 4186/4885
US-20250250226-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NCL, RNASE1, RNMT FAAH 4419/4885MGLL 3231/4885CNR1 4186/4885
US-10167253-B2 Ionizable compounds and compositions and uses thereof NCL, CHMP4B, RNASE1 FAAH 3999/4885MGLL 2871/4885CNR1 3674/4885
US-20160376229-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NCL, CHMP4B, RNASE1 FAAH 3999/4885MGLL 2871/4885CNR1 3674/4885
US-11384051-B2 Ionizable compounds and compositions and uses thereof NCL, CHMP4B, RNASE1 FAAH 3999/4885MGLL 2871/4885CNR1 3674/4885
US-20190127318-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NCL, CHMP4B, RNASE1 FAAH 3999/4885MGLL 2871/4885CNR1 3674/4885
US-12319643-B2 Ionizable compounds and compositions and uses thereof NCL, RNASE1, RNMT FAAH 4419/4885MGLL 3231/4885CNR1 4186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.